United States - English - NLM (National Library of Medicine)

glaxosmithkline llc - ezogabine (unii: 12g01i6bbu) (ezogabine - unii:12g01i6bbu) - ezogabine 50 mg - potiga® is indicated as adjunctive treatment of partial-onset seizures in patients aged 18 years and older who have responded inadequately to several alternative treatments and for whom the benefits outweigh the risk of retinal abnormalities and potential decline in visual acuity [see warnings and precautions (5.1)] . none. pregnancy category c. there are no adequate and well-controlled studies in pregnant women. potiga should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. in animal studies, doses associated with maternal plasma exposures (auc) to ezogabine and its major circulating metabolite, n-acetyl metabolite of ezogabine (namr), similar to or below those expected in humans at the maximum recommended human dose (mrhd) of 1,200 mg per day produced developmental toxicity when administered to pregnant rats and rabbits. the maximum doses evaluated were limited by maternal toxicity (acute neurotoxicity). treatment of pregnant rats with ezogabine (oral doses

Ireland - English - HPRA (Health Products Regulatory Authority)

rowa pharmaceuticals limited - magnesium - granules for oral solution - 5 millimole(s) - magnesium aspartate

Malta - English - Medicines Authority

g.l. pharma gmbh schlossplatz 1, 8502 lannach, austria - potassium iodide - tablet - potassium iodide 65 mg - all other therapeutic products

Canada - English - Health Canada

fresenius kabi canada ltd - magnesium sulfate - solution - 500mg - magnesium sulfate 500mg - miscellaneous anticonvulsants

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 97mg (4mmol)) chewable tablets (neoceuticals ltd - magnesium glycerophosphate - chewable tablet - 97.2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

magnesium 10mmol) oral powder sachets (kora healthcare - magnesium aspartate - powder for oral solution - 243mg

Ireland - English - HPRA (Health Products Regulatory Authority)

foran healthcare limited, - magnesium sulfate dried - cutaneous paste - 38.5 percent weight/weight - other dermatologicals; magnesium sulfate

Ireland - English - HPRA (Health Products Regulatory Authority)

g.l. pharma gmbh - potassium iodide - tablet - 65 milligram(s) - antidotes; potassium iodide

United States - English - NLM (National Library of Medicine)

select brand dist. - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.6 ml - saline laxative - relieves occasional constipation (irregularity) - generally produces bowel movement in 1/2 to 6 hours

United States - English - NLM (National Library of Medicine)

select brand dist. - magnesium citrate (unii: rho26o1t9v) (magnesium cation - unii:t6v3lhy838) - magnesium citrate 1.745 g in 29.6 ml - saline laxative - relieves occasional constipation (irregularity) - generally produces bowel movement in 1/2 to 6 hours